Veracyte, Inc.
VCYT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,703 | $2,114 | $2,314 | $3,073 |
| - Cash | $316 | $219 | $186 | $239 |
| + Debt | $40 | $51 | $51 | $51 |
| Enterprise Value | $2,428 | $1,945 | $2,178 | $2,885 |
| Revenue | $132 | $130 | $114 | $119 |
| % Growth | 1.3% | 13.7% | -3.5% | – |
| Gross Profit | $89 | $90 | $80 | $79 |
| % Margin | 67.8% | 69% | 69.5% | 66.4% |
| EBITDA | $24 | $7 | $7 | $10 |
| % Margin | 18.3% | 5.2% | 5.7% | 8.2% |
| Net Income | $19 | -$1 | $7 | $5 |
| % Margin | 14.5% | -0.8% | 6.2% | 4.3% |
| EPS Diluted | 0.24 | -0.013 | 0.088 | 0.06 |
| % Growth | 2,020.8% | -114.2% | 46.7% | – |
| Operating Cash Flow | $45 | $34 | $5 | $25 |
| Capital Expenditures | -$3 | -$1 | -$2 | -$4 |
| Free Cash Flow | $42 | $32 | $4 | $20 |